[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![$bioa Graphic](https://lunarcrush.com/gi/w:26/t:$bioa.png) $bioa

$BIOA sees positive sentiment with Leqembi's approval in China and its US launch. However, a broader selloff in biotech stocks may be impacting the stock.

### About $bioa
Social media analysis of $BIOA, likely a stock ticker symbol for a biotechnology company.  

### Engagements: X [#](/topic/$bioa/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$bioa/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$bioa/time-series/interactions.tsv)  
**Current Value**: X  
**Daily Average**: XXXXX  
**1 Week**: XXX -XX%  
**1 Month**: XXXXX -XX%  
**1-Year High**: XXXXXX on 2025-08-29  
**1-Year Low**: X on 2025-06-01  

| Social Network | X |
| -------------- | - |
| Engagements    | X |
  

  
  
### Mentions: X [#](/topic/$bioa/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$bioa/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$bioa/time-series/posts_active.tsv)  
**Current Value**: X  
**Daily Average**: XX  
**1 Month**: XX -XX%  
**1-Year High**: XXX on 2025-06-27  
**1-Year Low**: X on 2025-05-26  

| Social Network | X |
| -------------- | - |
| Mentions       | X |
  

  
  
### Creators: X [#](/topic/$bioa/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$bioa/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$bioa/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning $bioa in the last XX hours which is up XXX% from X in the previous XX hours
**Daily Average**: XX  
**1 Month**: X -XX%  
**1-Year High**: XXX on 2025-06-27  
**1-Year Low**: X on 2025-05-26  

The most influential creators that mention $bioa in the last XX hours

| Creator                                          | Rank | Followers | Posts | Engagements |
| -------                                          | ---- | --------- | ----- | ----------- |
| [@MarcJacksonLA](/creator/twitter/MarcJacksonLA) | X    | XXXXX     | X     | XX          |

[View More](/list/creators/$bioa/100)

**Top assets mentioned**
In the posts about $bioa in the last XX hours

[Cytokinetics Inc. (CYTK)](/topic/$cytk)
[Mineralys Therapeutics, Inc. Common Stock (MLYS)](/topic/$mlys)
[Biohaven Pharmaceutical Holding Company Ltd. (BHVN)](/topic/$bhvn)
[United Therapeutics, Corp. (UTHR)](/topic/united-therapeutics-corp)
[Sanofi (SNY)](/topic/sanofi)
[ROGin AI (ROG)](/topic/$rog)
[Alphabet Inc Class A (GOOGL)](/topic/$googl)
[Intellia Therapeutics, Inc (NTLA)](/topic/$ntla)

**Top topics mentioned**
In the posts about $bioa in the last XX hours

[stocks healthcare](/topic/stocks-healthcare), [$esaiy](/topic/$esaiy), [iv](/topic/iv), [$4523t](/topic/$4523t), [$cytk](/topic/$cytk), [$mlys](/topic/$mlys), [$bhvn](/topic/$bhvn), [united therapeutics corp](/topic/united-therapeutics-corp), [$vtyx](/topic/$vtyx), [sanofi](/topic/sanofi), [$rog](/topic/$rog), [stocks](/topic/stocks), [china](/topic/china), [united states](/topic/united-states), [$googl](/topic/$googl), [stocks communication services](/topic/stocks-communication-services), [$ampx](/topic/$ampx), [$ntla](/topic/$ntla), [$mdxh](/topic/$mdxh)

### Top Social Posts [#](/topic/$bioa/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"💼 $GOOGL Google $AMPX Amprius Technologies $NTLA Intellia Therapeutics $MDXH MDxHealth $AIRO Airo Group $OSSD OssDsign $SGMO Sangamo Therapeutics $SRPT Sarepta Therapeutics $NKTR Nektar Therapeutics $MCLAIR Medclair $NOVO Novo Nordisk $BIOA BioArctic"  
[X Link](https://x.com/Drbagholders/status/1975612700110794883) [@Drbagholders](/creator/x/Drbagholders) 2025-10-07T17:22Z XXX followers, 1298 engagements


"$BIOA $ESAIY Leqembi Iqlik (lecanemab-irmb) maintenance treatment launched in the United States BioArctic partner Eisai launched Leqembi Iqlik (lecanemab-irmb) subcutaneous autoinjector in the U.S. on October X 2025 as a maintenance option for early Alzheimers disease (MCI or mild dementia) after an initial 18-month IV induction. After XX months of XX mg/kg IV every two weeks patients may continue IV every four weeks or switch to a weekly XXX mg at-home subcutaneous injection. The company also launched a Leqembi Companion program with nurse education financial/insurance support an injection"  
[X Link](https://x.com/MarcJacksonLA/status/1975332616623825261) [@MarcJacksonLA](/creator/x/MarcJacksonLA) 2025-10-06T22:49Z 7577 followers, XXX engagements


"$VTYX Have still my shares from the first data run up in spring/summer. Sanofi has first right to negotiate here. Smells like something coming. NLRP3 is en vogue right now. $ROG showed their own NLRP3 some weeks ago. $BIOA also with NLRP3 data end of the year"  
[X Link](https://x.com/Lord_of_Biotech/status/1973401285551427705) [@Lord_of_Biotech](/creator/x/Lord_of_Biotech) 2025-10-01T14:55Z 3309 followers, 2680 engagements


"$BIOA $ESAIY Leqembi approved for IV maintenance treatment in China BioArctic announced that its partner Eisai has received approval from China's NMPA for Leqembi's (lecanemab) IV maintenance treatment in early Alzheimer's disease. The new approval allows for a maintenance dosing regimen of XX mg/kg once every four weeks after an 18-month initiation phase of bi-weekly dosing. Leqembi initially approved in China in January 2024 is notable as the only approved therapy targeting both amyloid plaque and protofibrils in Alzheimer's disease treatment. The drug was developed through a collaboration"  
[X Link](https://x.com/MarcJacksonLA/status/1972551114496393485) [@MarcJacksonLA](/creator/x/MarcJacksonLA) 2025-09-29T06:36Z 7577 followers, XXX engagements